KELVIN NEU, M.D.

Corporate Board Profile

Tech Score: 50/100

← Back to All Directors

Software Technology Evidence

1 mention(s) identify KELVIN NEU, M.D. as having software/technology expertise.

Company Filing Date Evidence Reason
XOMA Royalty Corp 2014-04-11 Dr. Neu holds an M.D. from Harvard Medical School-MIT Health Sciences and Technology program and spent three years in the Immunology Ph.D. program at Stanford University as a Howard Hughes Medical Institute Fellow. Dr. Neu holds an A.B. from Princeton University, where he was awarded the Khoury Prize for graduating first in his department of Molecular Biology. Holds an M.D. and spent three years in the Immunology Ph.D. program at Stanford University as a Howard Hughes Medical Institute Fellow, with a scientific background including molecular biology, indicating technical skills relevant to programming.

XOMA Royalty Corp

Filing Date Source Excerpt
2013-04-11 Dr. Neu holds an A.B. (Summa Cum Laude) in Molecular Biology from Princeton University, and an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology. Dr Neu also spent three years in the Immunology Ph.D. program at Stanford University.
2014-04-11 Dr. Neu holds an M.D. from Harvard Medical School-MIT Health Sciences and Technology program and spent three years in the Immunology Ph.D. program at Stanford University as a Howard Hughes Medical Institute Fellow. Dr. Neu holds an A.B. from Princeton University, where he was awarded the Khoury Prize for graduating first in his department of Molecular Biology.

Data sourced from SEC filings. Last updated: 2025-07-01